# Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

> **NCT00023725** · PHASE1,PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group**

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** semaxanib
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00023725
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023725, "Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00023725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*